Organicell Regenerative Medicine, Inc. filed its 10-K on Feb 14, 2023 for the period ending Oct 31, 2022. In this report its auditor, Marcum LLP, gave an unqualified opinion expressing doubt that the company can continue as a going concern.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.03 USD | +41.96% |
|
+20.83% | +99.02% |
06-14 | Zeo ScientifiX, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended April 30, 2024 | CI |
06-03 | Zeo Scientifix, Inc. Announces Management Changes | CI |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+99.02% | 12.85M | |
+26.32% | 75.86B | |
-4.23% | 23.51B | |
+15.24% | 8.76B | |
+1.96% | 8.31B | |
-33.21% | 6.66B | |
+19.66% | 5.45B | |
+0.89% | 4.05B | |
-8.73% | 3.8B | |
-9.28% | 3.33B |
- Stock Market
- Equities
- ZEOX Stock
- News Zeo ScientifiX, Inc.
- Organicell Regenerative Medicine, Inc. Auditor Raises 'Going Concern' Doubt